VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $825,170,000 | +15.3% | 8,117,753 | +102.3% | 25.22% | +78.3% |
| Q3 2015 | $715,937,000 | +5.5% | 4,013,551 | +31.4% | 14.14% | +19.9% |
| Q2 2015 | $678,724,000 | +30.3% | 3,055,251 | +16.5% | 11.79% | +5.7% |
| Q1 2015 | $521,033,000 | -1.4% | 2,623,268 | -29.0% | 11.16% | -25.9% |
| Q4 2014 | $528,686,000 | -9.6% | 3,694,263 | -17.1% | 15.06% | +17.4% |
| Q3 2014 | $584,778,000 | +18.8% | 4,457,153 | +14.2% | 12.82% | -5.9% |
| Q2 2014 | $492,231,000 | +28.2% | 3,902,877 | +34.0% | 13.63% | +10.7% |
| Q1 2014 | $384,028,000 | -4.6% | 2,913,051 | -15.0% | 12.32% | -7.2% |
| Q4 2013 | $402,455,000 | +6.2% | 3,428,063 | -5.6% | 13.27% | +39.2% |
| Q3 2013 | $378,960,000 | +14.3% | 3,632,322 | -5.7% | 9.54% | -26.9% |
| Q2 2013 | $331,435,000 | – | 3,850,317 | – | 13.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |